Prostate Cancer | Tumor

Educated Patient® Prostate Cancer Summit: September 26, 2020

October 15th 2020

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Penis Implants, Other Devices Help Improve Quality of Life Issues in Men Following Prostate Cancer Treatment

October 15th 2020

Men may experience erectile dysfunction and incontinence after receiving treatment for prostate cancer. However, there are devices — like a penile prosthetic and artificial urinary sphincter — that can help control those side effects associated with treatment.

Exercise, Diet Can Boost Bone Health in Prostate Cancer

October 14th 2020

Prostate cancer treatment can be detrimental to bone and muscle health, but an exercise regimen and healthy eating habits can help.

The Role of Surgery in Prostate Cancer Treatment

October 12th 2020

Some patients are better suited for surgery than others. In general, patients with widespread metastatic disease are also not good candidates for surgery, particularly if their cancer has spread beyond the prostate to areas like the liver, lungs, and bones.

Breaking Down Radiation Therapy for Prostate Cancer

October 12th 2020

Active surveillance can be used for many patients with prostate cancer; however, when localized, radiation therapy is an option.

Detecting Prostate Cancer Without Overtreatment Is Difficult

October 4th 2020

Finding balance to detect and treat prostate cancer without overtreatment is important for patients.

PARP Inhibitors Will Add a Treatment Option for Men with Metastatic Prostate Cancer

October 3rd 2020

PARP inhibitors are not only expanding the field of prostate cancer but they're giving men another option for life after cancer.

Where is The Balance Between Prostate Cancer Screening and Overtreatment?

October 2nd 2020

After a recommendation against routine prostate cancer screening, rates of early disease declined while the incidence of advanced disease rose. The trend highlights the difficult balance between screening and potential overtreatment.

PARP Inhibitors Demonstrate the Value of Targeted Treatments in Prostate Cancer

October 1st 2020

Primed to knock out cells vulnerable due to DNA-repair problems, PARP inhibitors are ushering in a targeted-drug era in prostate cancer treatment.

Phase 2 Study of VERU-111 in Prostate Cancer Subgroup Completes Patient Enrollment

September 30th 2020

VERU Inc. announced it has completed enrollment of 40 men with metastatic prostate cancer who have become resistant to at least one androgen receptor targeting agent for its phase 2 study of VERU-111.

Treatments for Men Whose Prostate Cancer Has Spread and Become Resistant to Hormonal Therapy are Growing

September 29th 2020

A growing number of treatments are available to men whose prostate cancer has spread and become resistant to hormonal therapy.

Coalition to Focus on Health Disparities Black Men with Prostate Cancer Face

September 28th 2020

Forward Momentum, a coalition launched by a biopharmaceutical company and three partners, focuses on the health disparities faced by Black men with prostate cancer.

Advances in Prostate Cancer

September 28th 2020

Future Use of PARP Inhibition in Prostate Cancer

September 28th 2020

Advice to Patients Facing mCRPC

September 28th 2020

PARP Inhibitors in Recurrent mCRPC

September 28th 2020

Treatment Options Available for mCRPC

September 28th 2020

John Litten: Participating on a PARP Clinical Trial for mCRPC

September 28th 2020

Talking About Gene Testing in Prostate Cancer

September 28th 2020

Testing for Mutations in Prostate Cancer

September 28th 2020

Prostate Cancer: Learning About Treatment Options

September 28th 2020

Receiving a Prostate Cancer Diagnosis

September 28th 2020

Metastatic Castration-Resistant Prostate Cancer Overview

September 28th 2020

The Future of PARP Inhibitors in Prostate Cancer

September 28th 2020

Patient’s Role in Decision-Making for Prostate Cancer

September 28th 2020

Quality of Life With Prostate Cancer

September 28th 2020

FDA-Approved PARP Inhibitors for Prostate Cancer

September 28th 2020

Impact of BRCA Mutations in Prostate Cancer

September 28th 2020

Genetic Counseling for Prostate Cancer

September 28th 2020

Diagnosis of Prostate Cancer

September 28th 2020